Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
224 participants
OBSERVATIONAL
2009-01-31
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators want to test the value of perirenal fat as surrogate of visceral obesity as risk factor for morbidity in colorectal surgery and to compare it to the effect of Body mass index (BMI) and Waist- Hip ratio (WHR).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life and High-Risk Abdominal Cancer Surgery
NCT04444544
Laparoscopic Versus Open Surgery for Colon Cancer With Visceral Obesity
NCT07314996
Predictive Value of Procalcitonin, CRP, Drain Fluid Culture, Il-6 and Tnf-α in Anastomotic Leakage
NCT02361918
Comparison of Laparoscopic and Open Surgery for Colorectal Malignancy in Obese Patients
NCT06221878
Short-term and Oncological Outcomes of Laparoscopic Colorectal Cancer Surgery in Obese Patients
NCT04716062
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Perirenal fat
Colorectal surgery
Colorectal surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Colorectal surgery
Colorectal surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* emergency condition
* immunosuppression
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Geneva
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Francesco Volonté, MD
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Minoa Jung, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Geneva
Francesco Volonte, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Geneva
Philippe Morel, MD
Role: STUDY_CHAIR
University Hospital, Geneva
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Geneva
Geneva, Canton of Geneva, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FAT-40-GVA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.